Form 4: Amphastar Pharmaceuticals Executive Yakob Liawatidewi Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Yakob Liawatidewi, EVP Corp Admin Center at Amphastar Pharmaceuticals, reports disposition of shares to cover tax liabilities related to vesting of restricted stock units.

Summary

  • On March 15, 2025, Yakob Liawatidewi disposed of 1,031 shares of Amphastar Pharmaceuticals common stock at a price of $26.66 per share to cover tax liabilities.
  • Following this transaction, Liawatidewi directly owns 92,640 shares of common stock.
  • On March 17, 2025, Liawatidewi disposed of 1,731 shares of Amphastar Pharmaceuticals common stock at a price of $27.69 per share to cover tax liabilities.
  • Following this transaction, Liawatidewi directly owns 90,909 shares of common stock.
  • Liawatidewi also indirectly owns 2,459 shares through the Yakob and Sunmoon Trust dated July 25, 2013, where Liawatidewi serves as a trustee.

Sentiment

Score: 5

Explanation: This is a neutral filing related to routine stock transactions for tax purposes. It doesn't indicate a positive or negative outlook for the company.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

  • The transactions have a minimal impact on shareholders, as they are related to tax obligations and do not represent a significant change in ownership.

Key Dates

DateDescription
July 25, 2013Date of the Yakob and Sunmoon Trust
03/15/2025Date of first reported transaction
03/17/2025Date of second reported transaction
03/18/2025Date of signature on the report

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.